Summary and References

Headaches are a common neurological symptom that can be classified into primary and secondary types. Primary headaches, like tension-type headache, migraine, and cluster headache, occur independently and are not associated with underlying conditions. Secondary headaches result from underlying causes. Understanding the clinical presentation, risk factors, and demographics associated with headaches is crucial for accurate diagnosis and management. Key learning points include recognizing the distinct features of different headache types, considering red flag symptoms for referral, and tailoring treatment approaches based on the specific headache diagnosis. Proper management can greatly improve patients’ quality of life and alleviate symptoms.

References

1. Orr SL, Friedman BW, Christie S, et al. Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache. 2016;56(6):911-940.
2. Godwin SA, Cherkas DS, Panagos PD, et al. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache. Ann Emerg Med. 2019;74(4):e41-e74.
3. Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008;336(7657):1359-1361.
4. Kelly AM, Klim S. Sumatriptan for the acute treatment of episodic migraine and cluster headache. Expert Opin Pharmacother. 2015;16(1):73-80.
5. Friedman BW, Irizarry E, Solorzano C, et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Neurology. 2017;89(20):2075-2082.
6. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):487-499.
7. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996;14(3):262-264.
8. Marmura MJ. Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies. Headache. 2018;58(1):109-111.
9. Freitag FG. Acute Treatment of Migraine: Overview of Randomized Placebo-Controlled Trials. Headache. 2018;58(7):997-1004.
10. Tepper SJ. Acute Treatment of Migraine. Continuum (Minneap Minn). 2019;25(4 Headache):1094-1112.
11. Friedman BW, West JM. Diagnosis and Treatment of Headache Patients in the Emergency Department. Emerg Med Clin North Am. 2015;33(2):417-432.